UNIGE document Scientific Article - Review
previous document  unige:39528  next document
add to browser collection


Published in Revue médicale suisse. 2005, vol. 1, no. 1, p. 39-42
Abstract Alternative to nephrotoxic calcineurin inhibitors regimens are feasible in renal transplantation. Sirolimus is an effective immunosuppressive drug with less drug-induced nephrotoxicity. Enteric-coated mycophenolate sodium provides a safety and efficacy alternative to mycophenolate mofetil. In peritoneal effluent, cancer antigen 125 (Ca 125) is a mesothelial cell marker and of in vivo biocompatibility of the new dialysis solutions. Longterm PD and peritoneal sclerosis are associated with a low number of mesothelial cells and a low concentration of dialysate Ca 125. Exposure to glucose and degradation products (GDPs) is important in the genesis of mesothelial damage. Short results of the more biocompatible solutions are promising (increasing of Ca 125). In the future, exposure to glucose can be reduced by using combinations of various osmotic agents, each in a low concentration (glycerol and amino acid solution).
Keywords HumansImmunosuppressive Agents/therapeutic useKidney Diseases/therapyKidney TransplantationMycophenolic Acid/therapeutic usePeritoneal DialysisSirolimus/therapeutic use
PMID: 15773197
Full text
Article (Published version) (623 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Groupe Pierre-Yves Martin (néphrologie) (30)
Cultures cellulaires et transplantations (519)
(ISO format)
MARANGON, Nicola Danièle Armando et al. Néphrologie. In: Revue médicale suisse, 2005, vol. 1, n° 1, p. 39-42. https://archive-ouverte.unige.ch/unige:39528

332 hits

0 download


Deposited on : 2014-08-19

Export document
Format :
Citation style :